Healthcare -
Biotechnology - NASDAQ - US
$ 43.55
-2.09 %
$ 1.67 B
Market Cap
-14.19
P/E
TARS - REVENUE
Revenue TARS - Tarsus Pharmaceuticals, Inc.
17.4 M
LAST VALUE
-44.69%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR